The 5 analysts offering 12-month price forecasts for ABIOMED Inc have a median target of 390.00, with a high estimate of 425.00 and a low estimate of 260.00. The median estimate represents a +53.08% increase from the last price of 254.77.
The current consensus among 9 polled investment analysts is to Buy stock in ABIOMED Inc. This rating has held steady since June, when it was upgraded from a Hold rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $1.06
Reporting Date Aug 03
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.